Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events

Background— Platelets participate in events that immediately precede acute myocardial infarction. Because platelets lack nuclear DNA but retain megakaryocyte-derived mRNAs, the platelet transcriptome provides a novel window on gene expression preceding acute coronary events. Methods and Results— We profiled platelet mRNA from patients with acute ST-segment–elevation myocardial infarction (STEMI, n=16) or stable coronary artery disease (n=44). The platelet transcriptomes were analyzed and single-gene models constructed to identify candidate genes with differential expression. We validated 1 candidate gene product by performing a prospective, nested case-control study (n=255 case-control pairs) among apparently healthy women to assess the risk of future cardiovascular events (nonfatal myocardial infarction, nonfatal stroke, and cardiovascular death) associated with baseline plasma levels of the candidate protein. Platelets isolated from STEMI and coronary artery disease patients contained 54 differentially expressed transcripts. The strongest discriminators of STEMI in the microarrays were CD69 (odds ratio 6.2, P<0.001) and myeloid-related protein-14 (MRP-14; odds ratio 3.3, P=0.002). Plasma levels of MRP-8/14 heterodimer were higher in STEMI patients (17.0 versus 8.0 &mgr;g/mL, P<0.001). In the validation study, the risk of a first cardiovascular event increased with each increasing quartile of MRP-8/14 (Ptrend<0.001) such that women with the highest levels had a 3.8-fold increase in risk of any vascular event (P<0.001). Risks were independent of standard risk factors and C-reactive protein. Conclusions— The platelet transcriptome reveals quantitative differences between acute and stable coronary artery disease. MRP-14 expression increases before STEMI, and increasing plasma concentrations of MRP-8/14 among healthy individuals predict the risk of future cardiovascular events.

[1]  P. Bugert,et al.  Letter by Krishnan et al regarding article, "Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events". , 2007, Circulation.

[2]  K. Swoboda,et al.  Escaping the Nuclear Confines: Signal-Dependent Pre-mRNA Splicing in Anucleate Platelets , 2005, Cell.

[3]  J. Manson,et al.  A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women , 2005, The New England journal of medicine.

[4]  I. Thorey,et al.  MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes. , 2004, Blood.

[5]  K. Clauser,et al.  Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[6]  H. Drexhage,et al.  Increased serum levels of MRP-8/14 in type 1 diabetes induce an increased expression of CD11b and an enhanced adhesion of circulating monocytes to fibronectin. , 2004, Diabetes.

[7]  Peter Bugert,et al.  Messenger RNA profiling of human platelets by microarray hybridization , 2003, Thrombosis and Haemostasis.

[8]  A. Weyrich,et al.  Evaluating the relevance of the platelet transcriptome. , 2003, Blood.

[9]  W. Nacken,et al.  S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity , 2003, Microscopy research and technique.

[10]  R. Donato,et al.  Intracellular and extracellular roles of S100 proteins , 2003, Microscopy research and technique.

[11]  P. Perrotta,et al.  Transcript profiling of human platelets using microarray and serial analysis of gene expression. , 2003, Blood.

[12]  M. Schemper,et al.  A solution to the problem of separation in logistic regression , 2002, Statistics in medicine.

[13]  P. Libby,et al.  Inflammation and thrombosis: the clot thickens. , 2001, Circulation.

[14]  C. Sorg,et al.  Transendothelial migration of 27E10+ human monocytes. , 2000, International immunology.

[15]  P. Ridker,et al.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. , 2000, The New England journal of medicine.

[16]  J. Mauël,et al.  CD69 and regulation of the immune function. , 1999, Immunopharmacology and immunotoxicology.

[17]  A. Bretscher,et al.  The cytoskeletal linker protein moesin: decreased levels in Wiskott‐Aldrich syndrome platelets and identification of a cleavage pathway in normal platelets , 1999, British journal of haematology.

[18]  M. Neurath,et al.  RAGE Mediates a Novel Proinflammatory Axis A Central Cell Surface Receptor for S100/Calgranulin Polypeptides , 1999, Cell.

[19]  John F. Martin,et al.  A role for changes in platelet production in the cause of acute coronary syndromes. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[20]  N. Hogg,et al.  Signaling mechanisms and the activation of leukocyte integrins , 1997, Journal of leukocyte biology.

[21]  R. Testi,et al.  CD69 is expressed on platelets and mediates platelet activation and aggregation , 1990, The Journal of experimental medicine.

[22]  J. Gorski,et al.  Enzymatic amplification of platelet-specific messenger RNA using the polymerase chain reaction. , 1988, The Journal of clinical investigation.

[23]  W. Vainchenker,et al.  Biosynthesis of major platelet proteins in human blood platelets. , 1987, European journal of biochemistry.

[24]  L Morgenstern,et al.  Coronary angioscopy in patients with unstable angina pectoris. , 1986, The New England journal of medicine.

[25]  M J Davies,et al.  Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. , 1985, British heart journal.

[26]  M S Golden,et al.  Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. , 1980, The New England journal of medicine.